Processa Pharmaceuticals
Biotechnology ResearchMaryland, United States11-50 Employees
Processa Pharmaceuticals is a clinical-stage biotechnology company focused on developing next-generation chemotherapy drugs. It aims to address unmet medical needs by pursuing therapies that may improve survival or quality of life for patients. The company is headquartered in Hanover, Maryland, and was founded in October 2017. Operating within the biotechnology research industry, Processa positions itself as a specialized developer of oncology-focused therapies. Its target market includes patients with limited treatment options and clinicians seeking more effective or tolerable treatments. A recent news item notes that the company is actively developing next-generation chemotherapy drugs.